-
Je něco špatně v tomto záznamu ?
Contribution of methamphetamine and insulin to the death of a woman suffering from type I diabetes - which played the greater role
K. Handlosová, P. Šištík, M. Uvíra, K. Andelova, P. Handlos, D. Stejskal
Forensic science, medicine, and pathology.
2025 ;
21 (1) :
502-506.
[pub] 20240704
Jazyk angličtina Země Spojené státy americké
Typ dokumentu kazuistiky, časopisecké články
Perzistentní odkaz
https://www.medvik.cz/link/bmc25009776
- MeSH
- bezvědomí chemicky indukované MeSH
- C-peptid krev MeSH
- diabetes mellitus 1. typu * MeSH
- dospělí MeSH
- fatální výsledek MeSH
- hypoglykemika škodlivé účinky MeSH
- inzulin * aplikace a dávkování MeSH
- krevní glukóza analýza MeSH
- lidé MeSH
- methamfetamin * škodlivé účinky MeSH
- poruchy spojené s užíváním amfetaminu komplikace MeSH
- stimulanty centrálního nervového systému * škodlivé účinky MeSH
- tanec MeSH
- tělesná námaha MeSH
- záchvaty MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- kazuistiky MeSH
This report presents a fatal case of a young female Type I diabetic patient who developed convulsions and loss of consciousness after taking methamphetamine and spending some time in a dance club. During the convulsions, she was given sugar and when no response occurred, her boyfriend who was not experienced in the use of insulin administered a dose of insulin to her. The woman lost consciousness and died despite the efforts of the emergency service. A biochemical analysis revealed a high level of insulin (196.67 mU/L) and low levels of glucose (2.96 mmol/L) and C-peptide (26 pmol/L). Toxicological analysis revealed a methamphetamine concentration of 389 ng/mL and an amphetamine concentration of 19 ng/mL. The forensic perspective of the difficult determination of the contribution of each of the factors to the death, i.e., the pre-existing medical condition (Type I diabetes), the use of methamphetamine, the physical exertion at the dance club, and, finally, the non-indicated administration of insulin, is discussed. The ruling of the court is also reported.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25009776
- 003
- CZ-PrNML
- 005
- 20250429135252.0
- 007
- ta
- 008
- 250415s2025 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s12024-024-00855-y $2 doi
- 035 __
- $a (PubMed)38965163
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Handlosová, Klára $u Department of Forensic Medicine, University Hospital Ostrava, Ostrava, 70852, Czech Republic $u Department of Forensic Medicine, Faculty of Medicine, University of Ostrava, Ostrava, 701 03, Czech Republic
- 245 10
- $a Contribution of methamphetamine and insulin to the death of a woman suffering from type I diabetes - which played the greater role / $c K. Handlosová, P. Šištík, M. Uvíra, K. Andelova, P. Handlos, D. Stejskal
- 520 9_
- $a This report presents a fatal case of a young female Type I diabetic patient who developed convulsions and loss of consciousness after taking methamphetamine and spending some time in a dance club. During the convulsions, she was given sugar and when no response occurred, her boyfriend who was not experienced in the use of insulin administered a dose of insulin to her. The woman lost consciousness and died despite the efforts of the emergency service. A biochemical analysis revealed a high level of insulin (196.67 mU/L) and low levels of glucose (2.96 mmol/L) and C-peptide (26 pmol/L). Toxicological analysis revealed a methamphetamine concentration of 389 ng/mL and an amphetamine concentration of 19 ng/mL. The forensic perspective of the difficult determination of the contribution of each of the factors to the death, i.e., the pre-existing medical condition (Type I diabetes), the use of methamphetamine, the physical exertion at the dance club, and, finally, the non-indicated administration of insulin, is discussed. The ruling of the court is also reported.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a methamfetamin $x škodlivé účinky $7 D008694
- 650 12
- $a diabetes mellitus 1. typu $7 D003922
- 650 12
- $a inzulin $x aplikace a dávkování $7 D007328
- 650 12
- $a stimulanty centrálního nervového systému $x škodlivé účinky $7 D000697
- 650 _2
- $a bezvědomí $x chemicky indukované $7 D014474
- 650 _2
- $a krevní glukóza $x analýza $7 D001786
- 650 _2
- $a C-peptid $x krev $7 D002096
- 650 _2
- $a záchvaty $7 D012640
- 650 _2
- $a fatální výsledek $7 D017809
- 650 _2
- $a tanec $7 D003615
- 650 _2
- $a hypoglykemika $x škodlivé účinky $7 D007004
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a tělesná námaha $7 D005082
- 650 _2
- $a poruchy spojené s užíváním amfetaminu $x komplikace $7 D019969
- 655 _2
- $a kazuistiky $7 D002363
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Šištík, Pavel $u Department of Clinical Pharmacology, Institute of Laboratory Medicine, University Hospital Ostrava, 17. listopadu 1790, Ostrava, 708 52, Czech Republic $u Institute of Laboratory Medicine, Faculty of Medicine, University of Ostrava, Syllabova 19, Ostrava, 703 00, Czech Republic $u Department of Clinical Pharmacology, Faculty of Medicine, University of Ostrava, Syllabova 19, Ostrava, 703 00, Czech Republic
- 700 1_
- $a Uvíra, Matěj $u Department of Forensic Medicine, University Hospital Ostrava, Ostrava, 70852, Czech Republic $u Department of Forensic Medicine, Faculty of Medicine, University of Ostrava, Ostrava, 701 03, Czech Republic
- 700 1_
- $a Andelova, Kateřina $u Institute of Laboratory Medicine, Faculty of Medicine, University of Ostrava, Syllabova 19, Ostrava, 703 00, Czech Republic $u Department of Clinical Biochemistry, Institute of Laboratory Medicine, University Hospital Ostrava, Ostrava, Czechia
- 700 1_
- $a Handlos, Petr $u Department of Forensic Medicine, University Hospital Ostrava, Ostrava, 70852, Czech Republic. petr.handlos@fno.cz $u Department of Forensic Medicine, Faculty of Medicine, University of Ostrava, Ostrava, 701 03, Czech Republic. petr.handlos@fno.cz
- 700 1_
- $a Stejskal, David $u Institute of Laboratory Medicine, Faculty of Medicine, University of Ostrava, Syllabova 19, Ostrava, 703 00, Czech Republic $u Department of Clinical Biochemistry, Institute of Laboratory Medicine, University Hospital Ostrava, Ostrava, Czechia
- 773 0_
- $w MED00181404 $t Forensic science, medicine, and pathology $x 1556-2891 $g Roč. 21, č. 1 (2025), s. 502-506
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38965163 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250415 $b ABA008
- 991 __
- $a 20250429135247 $b ABA008
- 999 __
- $a ok $b bmc $g 2311264 $s 1246857
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 21 $c 1 $d 502-506 $e 20240704 $i 1556-2891 $m Forensic science, medicine, and pathology $n Forensic Sci Med Pathol $x MED00181404
- LZP __
- $a Pubmed-20250415
